details

Donations in favor of cancer research at the NCT Heidelberg / UKHD, DKFZ and NCT join forces / DKFZ and NCT charity run merge / Savings for registrations up until the 31st of March

“RUNning against cancer, how far would you go?” The motto of this year’s charity run is the same as in previous years. This year, participants of the DKFZ run will join in. Furthermore numerous employees of the Heidelberg University Hospital (UKHD), patients, relatives and runners are expected on three different running tracks. Starting point will be at the Neuenheimer Feld. All donations will be used for cancer research at the NCT Heidelberg.

The DKFZ-run “Heidelberger Lauf für die Krebsforschung” (Heidelberg run for cancer research) will be merged into the NCT-run beginning this year. The NCT- run is one of the biggest charity runs in the region Rhein-Neckar. This year, around 5,000 people are expected on July 13.
“At the NCT, the DKFZ is joining forces with the University Hospital Heidelberg to bring research results to patients as quickly as possible”, says Josef Puchta, commercial director at the DKFZ. “Now we will also join forces at the NCT-run, because we can achieve more together. Runners can decide between a bigger variety of tracks and distances at the NCT-run. More runners can participate and therefore more money can be raised for cancer research.” Also, employees are welcome to participate.

The organizational preparations are going full speed. As per usual, runners can choose between round trips, a 10km distance and a half marathon. Also, there will be a social program with music, food, and drinks.
Groups and individual runners can sign up already on the website: www.nct-lauf.de. Up until the 31st of March prices for the half marathon and the 10km run are 25.00 and 20.00 Euro. Afterwards it will be cost more. The round trips cost 16.50 Euros for adults and 5 Euros for students. T-shirts are 19.50 Euros.
Together with the University Hospital, the DKFZ and all participants we want to hold something positive against cancer”, says Christof von Kalle, executive director at the NCT Heidelberg. “No matter if you are a student, patient, relative, employee or long distance runner; you are all invited to make a personal contribution against cancer. Round trips or half marathon everyone feels they are part of a good cause”.
Starting signal will go off at 7 pm on July 13 2018 at the Neuenheimer Feld. Please take a look at the following schedule. All information can be found on the website: www.nct-lauf.de

Schedule:
Date: Friday, July 13, 2018
Closing time for online registration: July 11th, 11:59 pm. (www.nct-lauf.de)
Last minute registration: July 13 (cash only)

Entry fees:
. NCT-round trips: 16,50 Euro adults, 5,00 Euro students
. NCT-10 km against cancer: 20,00 Euro (until March 31st, 2018, then staggered prices)
. NCT-half-marathon: 25,00 Euro (until March 31st, 2018, then staggered prices)

Distance: round trips, about 2,7 km, flat, without traffic, drinks will be provided at the start and finish Start and finish line: Im Neuenheimer Feld (exact location will be published soon)

contact: Jörg Fleckenstein, Tel.: 06221 56-5755, joerg.fleckenstein@nct-heidelberg.de

Program
7 pm: beginning of the half marathon and the 10km run
7:15 pm: beginning of the track run
10:00 pm: end of time tracking
11:00 pm: end of the event

Pictures accompanying the press release can be found on the internet free of charge:

https://www.nct-heidelberg.de/fileadmin/media/news/Meldungen/Bilder/nct_lauf_0715_0483.jpg

https://www.nct-heidelberg.de/fileadmin/media/news/Meldungen/Bilder/NCT-Lauf_0717_7163.jpg
caption: The NCT is happy that runners of the DKFZ run join this year’s NCT run.
https://www.nct-heidelberg.de/fileadmin/media/news/Meldungen/Bilder/Laufschuhe.jpg
caption: put on your running shoes and go: ist not about records but about a good cause!

Instructions for use of image material for press releases
Usage is free of charge. The NCT Heidelberg allows one-time use in connection with reporting on the topic of this press release. Please use credits as follows: "Copyright: NCT / Philip Benjamin". A transfer of the image material to third parties is permitted only after prior consultation with the NCT Press Office (Tel. 06221 56 5930, E-Mail: friederike.fellenberg@nct-heidelberg.de). Use for commercial purposes is prohibited.

Press contacts:
Dr. Friederike Fellenberg
Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg
Presse- und Öffentlichkeitsarbeit
Im Neuenheimer Feld 460
69120 Heidelberg
Tel.: +49 6221 56-5930
Fax: +49 6221 56-5350
E-Mail: friederike.fellenberg@nct-heidelberg.de
www.nct-heidelberg.de

Doris Rübsam-Brodkorb
Universitätsklinikum Heidelberg und Medizinische Fakultät der Universität Heidelberg
Presse- und Öffentlichkeitsarbeit
Im Neuenheimer Feld 672
69120 Heidelberg
Tel.: +49 6221 56-5052
Fax: +49 6221 56-4544
E-Mail: doris.ruebsam-brodkorb@med.uni-heidelberg.de
www.klinikum.uni-heidelberg.de

Dr. Sibylle Kohlstädt
Deutsches Krebsforschungszentrum (DKFZ)
Presse- und Öffentlichkeitsarbeit
Deutsches Krebsforschungszentrum
Im Neuenheimer Feld 280
69120 Heidelberg
Tel.: +49 6221 42-2843
Fax: +49 6221 42-2968
E-Mail: s.kohlstaedt@dkfz.de
www.dkfz.de

The National Center for Tumor Diseases (NCT) Heidelberg
The National Center for Tumor Diseases (NCT) Heidelberg is a joint institution of the German Cancer Research Center, Heidelberg University Hospital and German Cancer Aid. The NCT's goal is to link promising approaches from cancer research with patient care from diagnosis to treatment, aftercare and prevention. The interdisciplinary tumor outpatient clinic is the central element of the NCT. Here the patients benefit from an individual treatment plan prepared in a timely manner in interdisciplinary expert rounds, the so-called tumor boards. Participation in clinical studies provides access to innovative therapies. The NCT thereby acts as a pioneering platform that translates novel research results from the laboratory into clinical practice. The NCT cooperates with self-help groups and supports them in their work. 2015 the NCT Heidelberg established a partner location in Dresden.

The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)
The German Cancer Research Center (DKFZ) with its more than 3,000 employees is the largest biomedical research institute in Germany. At DKFZ, more than 1,000 scientists investigate how cancer develops, identify cancer risk factors and endeavor to find new strategies to prevent people from getting cancer. They develop novel approaches to make tumor diagnosis more precise and treatment of cancer patients more successful. The staff of the Cancer Information Service (KID) offers information about the widespread disease of cancer for patients, their families, and the general public. Jointly with Heidelberg University Hospital, DKFZ has established the National Center for Tumor Diseases (NCT) Heidelberg, where promising approaches from cancer research are translated into the clinic. In the German Consortium for Translational Cancer Research (DKTK), one of six German Centers for Health Research, DKFZ maintains translational centers at seven university partnering sites. Combining excellent university hospitals with high-profile research at a Helmholtz Center is an important contribution to improving the chances of cancer patients. DKFZ is a member of the Helmholtz Association of National Research Centers, with ninety percent of its funding coming from the German Federal Ministry of Education and Research and the remaining ten percent from the State of Baden-Württemberg.

Heidelberg University Hospital and Medical Faculty Heidelberg
Heidelberg University Hospital is one of the most important medical centers in Germany; Heidelberg University's Medical Faculty is one of Europe's most prestigious biomedical research facilities. Their shared objective is the development of innovative diagnostics and treatments and their prompt implementation for the benefit of the patient. The hospital and faculty employ approximately 12 600 individuals and are involved in training and qualification. Every year approximately 66 000 patients are treated as inpatients or day patients in more than 50 specialized clinical departments with about 1 900 beds, with more than 1 million patients being treated as outpatients. The Heidelberg Curriculum Medicinale (HeiCuMed) is at the forefront of medical training in Germany. At present approx. 3500 prospective physicians are studying in Heidelberg.